Sponsored by:

Nuclear Medicine: Page 170

Florbetapir shows promise in detecting cardiac amyloid
By Wayne Forrest
Preliminary study results indicate that F-18 florbetapir (Amyvid) can detect cardiac amyloidosis, a buildup of protein that can lead to various forms of heart disease. The results hint that Amyvid could be useful beyond its core indication of detecting beta-amyloid deposits in the brain.
July 15, 2013
Japanese government reimburses for PEM scans
By AuntMinnie.com staff writers
PET developer Naviscan announced that its Japanese distributor, SCETI, has received notification of reimbursement approval for Naviscan's positron emission mammography (PEM) scanner.
July 14, 2013
Radiopharma market may triple in 5 years
By AuntMinnie.com staff writers
New technological developments and research are poised to nearly triple the size of the radiopharmaceutical market by 2018, according to a new report by Transparency Market Research.
July 11, 2013
Lantheus CFO to leave firm
By AuntMinnie.com staff writers
Lantheus Medical Imaging said it will replace its chief financial officer (CFO), effective August 9.
July 11, 2013
Florbetaben-PET detects amyloid in people with Down syndrome
By Wayne Forrest
A new study using PET with a florbetaben radiopharmaceutical shows how people with Down syndrome begin to accumulate beta-amyloid deposits in their brains in their early 40s, putting this population at greater risk for the early onset of cognitive impairment.
July 10, 2013
2013 07 10 16 36 14 270 Seibyl Down Pet 450 20130710233838
FDG-PET, DWI-MRI help predict osteosarcoma chemo response
By Wayne Forrest
Combining FDG-PET/CT and diffusion-weighed MRI (DWI-MRI) may be useful for predicting the histologic response of osteosarcoma to neoadjuvant chemotherapy, according to a study published in the July issue of the Journal of Nuclear Medicine.
July 10, 2013
2013 07 10 14 53 40 631 Jnm Pet Ct Mri Osteosarcoma Byun 450 20130710215753
GE recalls NM systems; saving NM residencies; rads as gatekeepers
By Brian Casey
July 8, 2013
GE recalls gamma cameras after fatal accident
By Brian Casey
In the wake of a fatal accident in which a patient was crushed by one of its gamma cameras, GE Healthcare has advised users of many of its nuclear medicine systems to stop using the products until they have been inspected by GE service engineers.
July 8, 2013
SNMMI disagrees with CMS PET decision
By AuntMinnie.com staff writers
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) expressed its disappointment with the July 3 draft decision from the U.S. Centers for Medicare and Medicaid Services (CMS) regarding the use of beta-amyloid PET imaging agents.
July 8, 2013
Combo residency could address nuclear medicine job woes
By Eric Barnes
A survey of nuclear medicine residents found widespread dismay about the lack of job opportunities for newly minted nuclear medicine specialists, along with a strong conviction that combining residency programs with radiology is the only way to set things right, according to an article in the Journal of the American College of Radiology.
July 8, 2013
2013 07 08 13 45 54 547 Harolds Jay 200
Lilly 'disappointed' with CMS draft decision
By AuntMinnie.com staff writers
Eli Lilly and its subsidiary Avid Radiopharmaceuticals are expressing disappointment in the July 3 draft decision by the U.S. Centers for Medicare and Medicaid Services (CMS) that stopped short of fully endorsing PET beta-amyloid imaging for dementia or neurodegenerative disease.
July 4, 2013
NRC accepts Shine's isotope permit application
By AuntMinnie.com staff writers
The U.S. Nuclear Regulatory Commission (NRC) has accepted for review the first part of medical isotope firm Shine Medical Technologies' construction permit application.
July 3, 2013
Previous Page
Page 170 of 440
Next Page